Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Allsop

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Drug and Alcohol Review|June 7, 2014
Dedicated 'cannabis only' treatment clinics in New South Wales, Australia: client and treatment characteristics and associations with first-time treatment seekingJan Copeland, David Allsop
Essays in Biochemistry|August 19, 2014
Amyloid β-peptide and Alzheimer's diseaseDavid Allsop, Jennifer Mayes
Journal of Molecular Neuroscience : MN|September 10, 2017
α-Synuclein Interacts with Lipoproteins in PlasmaFatemeh Nouri Emamzadeh, David Allsop
International Journal of Alzheimer'S Disease|December 29, 2010
Hypothesis: soluble aβ oligomers in association with redox-active metal ions are the optimal generators of reactive oxygen species in Alzheimer's diseaseBrian J Tabner, Jennifer Mayes, David Allsop
Protein and Peptide Letters|June 9, 2004
Induction of cellular oxidative stress by the beta-amyloid peptide involved in Alzheimer's diseaseGillian L Gibson, David Allsop, Brian M Austen
International Journal of Nanomedicine|December 28, 2018
Liposome delivery systems for the treatment of Alzheimer's diseaseCallum Ross, Mark Taylor, Nigel Fullwood, et al.
Free Radical Biology & Medicine|June 21, 2011
The amylin peptide implicated in type 2 diabetes stimulates copper-mediated carbonyl group and ascorbate radical formationAtef Masad, Brian J Tabner, Jennifer Mayes, et al.
Interface Focus|November 18, 2017
Development of proteolytically stable N-methylated peptide inhibitors of aggregation of the amylin peptide implicated in type 2 diabetesIdira Obasse, Mark Taylor, Nigel J Fullwood, et al.
Biochemistry|June 25, 2003
Generation of hydrogen peroxide from mutant forms of the prion protein fragment PrP121-231Stuart Turnbull, Brian J Tabner, David R Brown, et al.
Neuroscience Letters|February 28, 2016
Effects of different isoforms of apoE on aggregation of the α-synuclein protein implicated in Parkinson's diseaseFatemeh Nouri Emamzadeh, Harmesh Aojula, Patrick C McHugh, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Drug and Alcohol Review|June 7, 2014
Dedicated 'cannabis only' treatment clinics in New South Wales, Australia: client and treatment characteristics and associations with first-time treatment seekingJan Copeland, David Allsop
Essays in Biochemistry|August 19, 2014
Amyloid β-peptide and Alzheimer's diseaseDavid Allsop, Jennifer Mayes
Journal of Molecular Neuroscience : MN|September 10, 2017
α-Synuclein Interacts with Lipoproteins in PlasmaFatemeh Nouri Emamzadeh, David Allsop
International Journal of Alzheimer'S Disease|December 29, 2010
Hypothesis: soluble aβ oligomers in association with redox-active metal ions are the optimal generators of reactive oxygen species in Alzheimer's diseaseBrian J Tabner, Jennifer Mayes, David Allsop
Protein and Peptide Letters|June 9, 2004
Induction of cellular oxidative stress by the beta-amyloid peptide involved in Alzheimer's diseaseGillian L Gibson, David Allsop, Brian M Austen
International Journal of Nanomedicine|December 28, 2018
Liposome delivery systems for the treatment of Alzheimer's diseaseCallum Ross, Mark Taylor, Nigel Fullwood, et al.
Free Radical Biology & Medicine|June 21, 2011
The amylin peptide implicated in type 2 diabetes stimulates copper-mediated carbonyl group and ascorbate radical formationAtef Masad, Brian J Tabner, Jennifer Mayes, et al.
Interface Focus|November 18, 2017
Development of proteolytically stable N-methylated peptide inhibitors of aggregation of the amylin peptide implicated in type 2 diabetesIdira Obasse, Mark Taylor, Nigel J Fullwood, et al.
Biochemistry|June 25, 2003
Generation of hydrogen peroxide from mutant forms of the prion protein fragment PrP121-231Stuart Turnbull, Brian J Tabner, David R Brown, et al.
Neuroscience Letters|February 28, 2016
Effects of different isoforms of apoE on aggregation of the α-synuclein protein implicated in Parkinson's diseaseFatemeh Nouri Emamzadeh, Harmesh Aojula, Patrick C McHugh, et al.
Pageof 7